Cellectar Bioscience(CLRB.US)

Last Updated 19:00:00 ET
longbridge loading

Cellectar Biosciences appoints Andrew Gu to board; Stefan D. Loren to step down, join as consultant

TradingView·
US
CLRB
-2.55%
US
BBH
+0.68%
US
VHT
+0.97%
TradingView·
US
CLRB
-2.55%
US
BBH
+0.68%
US
VHT
+0.97%

Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call

benzinga_article·
US
CLRB
-2.55%
US
XBI
-0.69%
US
PBE
+0.11%
benzinga_article·
US
CLRB
-2.55%
US
XBI
-0.69%
US
PBE
+0.11%

Cellectar Bioscience | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
CLRB
-2.55%
Earnings Watch·
US
CLRB
-2.55%

Earnings Scheduled For May 14, 2026

benzinga_article·
US
LWAY
+5.88%
US
UONE
+2.19%
US
CLRB
-2.55%
benzinga_article·
US
LWAY
+5.88%
US
UONE
+2.19%
US
CLRB
-2.55%

Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates | CLRB Stock News

StockTitan·
US
CLRB
-2.55%
US
BBH
+0.68%
US
XBI
-0.69%
StockTitan·
US
CLRB
-2.55%
US
BBH
+0.68%
US
XBI
-0.69%

CLRB Q1'26 Earnings: EPS estimate is (1.89) USD

TradingView·
US
CLRB
-2.55%
US
IBB
+0.10%
US
BIB
+0.05%
TradingView·
US
CLRB
-2.55%
US
IBB
+0.10%
US
BIB
+0.05%

Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026 | CLRB Stock News

StockTitan·
US
CLRB
-2.55%
US
IBB
+0.10%
US
ARKG
+0.04%
StockTitan·
US
CLRB
-2.55%
US
IBB
+0.10%
US
ARKG
+0.04%

Cellectar Biosciences Raises ~$35 Million in Registered Direct and Private Placement

TradingView·
US
CLRB
-2.55%
US
ARKG
+0.04%
US
BBH
+0.68%
TradingView·
US
CLRB
-2.55%
US
ARKG
+0.04%
US
BBH
+0.68%
© 2026 Longbridge｜Disclaimer